The 1st Annual Translational Microbiome Conference

 

Conference - Boston, MA, United States

 

This Conference will focus on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make this space successful.

Therapeutic areas of research with potential for actionable interventions to be covered at this conference include:

♦ Women's Health

♦ Obesity and Type 2 diabetes

♦ Pulmonology and COPD

♦ Immunology and the Impact of C. diffiicle Infections

♦ Dermatology

♦ Periodontal Disease

Research into the microbiome is still in its infancy and yet has already revealed its potential role in a host of diseases, including obesity, Type 2 diabetes, inflammatory bowel diseases, preterm birth and Urinary Tract Infections (UTIs), as well as numerous connections between the oral microbiome and systemic diseases such as rheumatoid arthritis, cardiac disease and pancreatic cancer. Reflective of the microbiome’s potential as “the most exciting frontier in medicine,” according to Francis Collins, Director, NIH, are the numerous collaborative research projects underway, such as the Integrative Human Microbiome Project Research Consortium and the Human Microbiome Project, as well as any number of consortia at research institutions as Stanford, Arizona State University and others.

 

 

If you'd like to ask a question or post a comment about this talk please do so below.